VALENCIA, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care ...
The Company will hold a conference call to discuss its results at 5:00 p.m. (Eastern Time ... Major target markets include aerospace & defense (ceramic matrix composites), high power electronics ...